The Nrf2 Activator, tBHQ, Differentially Affects Early Events Following Stimulation of Jurkat Cells

The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation

(2014) N. G. Innamorato et al.   JOURNAL OF IMMUNOLOGY

Benzo[a]pyrene affects Jurkat T cells in the activated state via the antioxidant response element dependent Nrf2 pathway leading to decreased IL-2 secretion and redirecting glutamine metabolism

(2013) Jayaseelan Murugaiyan et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Th2 Skewing by Activation of Nrf2 in CD4+ T Cells

(2012) C. E. Rockwell et al.   JOURNAL OF IMMUNOLOGY

Exposure of Jurkat cells to bis (tri-n-butyltin) oxide (TBTO) induces transcriptomics changes indicative for ER- and oxidative stress, T cell activation and apoptosis

(2011) Madhumohan R. Katika et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Role of the Tumor Suppressor PTEN in Antioxidant Responsive Element-mediated Transcription and Associated Histone Modifications

(2009) Kensuke Sakamoto et al.   MOLECULAR BIOLOGY OF THE CELL

The Absence of the Pro-antioxidant Transcription Factor Nrf2 Exacerbates Experimental Autoimmune Encephalomyelitis

(2009) Delinda A. Johnson et al.   TOXICOLOGICAL SCIENCES

Molecular mechanisms of Nrf2-mediated antioxidant response

(2008) Wenge Li et al.   MOLECULAR CARCINOGENESIS